Bone Cancer

Xgeva Delays Onset of Bone Metastases (09-27-2011)

Among men with prostate cancer that has stopped responding to hormonal therapy, the bone drug Xgeva™ (denosumab) delayed the spread of cancer to the bones. These results were presented at the 2011 European Multidisciplinary Cancer Conference. Androgen... Continue Reading

Clinical Trial Participation Is Inadequate (08-31-2011)

A large proportion of cancer patients do not enroll in clinical trials, and those who do participate may not adequately represent age groups, cancer stages, cancer types, and racial and ethnic groups. These findings were recently reported in the Annals... Continue Reading

Stay on Top of Your Family History of Cancer (07-15-2011)

People who are at high risk of cancer as a result of their family history may be advised to undergo earlier or more intensive cancer screening. Because family history of cancer can change over time, it’s important to update this information periodically... Continue Reading

Survivors of Childhood Cancer Face Risk of More Cancer (07-11-2011)

Children who survive cancer have an increased risk of developing cancer later in life. These findings were recently reported in the Journal of Clinical Oncology. The good news about childhood cancer is that increasingly more children are surviving. These... Continue Reading

New Substances Added to List of Cancer-Causing Agents (06-21-2011)

In the most recent version of the National Toxicology Program’s Report on Carcinogens, two new substances have been classified as “known human carcinogens” and six others have been classified as “reasonably anticipated to be human carcinogens.” The... Continue Reading

Medical Costs Higher Among Survivors (06-21-2011)

Cancer survivors tend to pay substantially more in annual medical costs compared with people who have never had cancer. These findings were recently reported in Cancer. A significant number of adults in the United States are cancer survivors—approximately... Continue Reading

Fewer Lung Cancer Deaths Among Women (04-11-2011)

The lung cancer death rate among women appears to be declining for the first time in 40 years, according to an annual report published by multiple institutions. Findings from the report were recently released in the Journal of the National Cancer Institute. A... Continue Reading

Cancer Care Costs Expected to Rise by at Least 27% Over Next Decade (01-18-2011)

As a result of the growth and aging of the US population, cancer care costs are expected to rise by 27% by the year 2020. This estimate does not include increases in the cost of cancer treatment itself, which would push expenditures even higher.  These... Continue Reading

Denosumab Active Against Giant Cell Tumor of Bone (02-11-2010)

In a Phase II clinical trial, denosumab produced high rates of tumor response among patients with recurrent or unresectable giant cell tumors of bone. These results were published in Lancet Oncology. Denosumab is an investigational drug that targets... Continue Reading

Denosumab Produces Promising Results Against Giant Cell Tumor of the Bone (06-5-2009)

Denosumab Produces Promising Results Against Giant Cell Tumor of the Bone In a Phase II clinical trial, 86% of patients with giant cell tumor of the bone responded to treatment with the investigational targeted therapy denosumab. These results were presented... Continue Reading

« Previous PageNext Page »